Lightship vs Saluda Medical

Side-by-side comparison of AI visibility scores, market position, and capabilities

Saluda Medical leads in AI visibility (74 vs 34)
Lightship logo

Lightship

EmergingLife Sciences & BioTech

Decentralized & Hybrid Clinical Trial Services

Lightship is a clinical research organization (CRO) specializing in decentralized and hybrid clinical trial design, combining in-clinic visits, at-home appointments, mobile research units, and digital health tools to improve participant access and.

AI VisibilityBeta
Overall Score
D34
Category Rank
#182 of 198
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
34
Perplexity
37
Gemini
29

About

Lightship is a clinical research organization (CRO) founded with the mission of reimagining how clinical trials are designed and conducted to dramatically improve participant access and health equity. Traditional clinical research requires participants to travel to major academic medical centers or specialized research sites for frequent, often burdensome in-clinic visits — a model that systematically excludes working adults, rural populations, elderly patients, and underrepresented communities. Lightship designs and executes studies using a spectrum of participation modalities: traditional in-clinic visits, at-home appointments with study nurses who travel to participants, mobile research units that bring clinical procedures to community locations, and digital health tools that enable remote data collection between visits.

Full profile
Saluda Medical logo

Saluda Medical

LeaderLife Sciences & BioTech

Neuromodulation & Spinal Cord Stimulation

Saluda Medical is the pioneer of closed-loop spinal cord stimulation (SCS); FDA-approved Evoke SCS system with real-time neural feedback; raised $100M in Jan 2025; received FDA clearance for automated EVA programming platform.

AI VisibilityBeta
Overall Score
B74
Category Rank
#10 of 198
AI Consensus
73%
Trend
stable
Per Platform
ChatGPT
72
Perplexity
68
Gemini
80

About

Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US operations in Marlborough, Massachusetts), Saluda''s flagship product is the Evoke Spinal Cord Stimulation (SCS) System — the world''s first SCS system that senses and measures neural responses to stimulation (evoked compound action potentials, or ECAPs) and automatically adjusts therapy in real time based on each patient''s neurophysiological feedback. This closed-loop approach provides more precise, consistent pain relief compared to conventional open-loop SCS systems.

Full profile

AI Visibility Head-to-Head

34
Overall Score
74
#182
Category Rank
#10
78
AI Consensus
73
stable
Trend
stable
34
ChatGPT
72
37
Perplexity
68
29
Gemini
80
30
Claude
71
29
Grok
71

Key Details

Category
Decentralized & Hybrid Clinical Trial Services
Neuromodulation & Spinal Cord Stimulation
Tier
Emerging
Leader
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.